跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMPICILLIN SODIUM FOR INJECTION BP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AMPICILLIN SODIUM FOR INJECTION BP
Authorized
STANDARD
AMPICILLIN SODIUM FOR INJECTION BP
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
aab38f210dacb1aa
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
aab38f210dacb1aa
Drug Approval Canada Name
AMPICILLIN SODIUM FOR INJECTION BP
Product Name
AMPICILLIN SODIUM FOR INJECTION BP
Status
Marketed
Status Date
2017-10-20
Original Market Date
2017-10-20
Din
02462303
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous , Intramuscular
Schedule
Prescription
Ahfs
08:12.16.08
Atc Original
J01CA01 AMPICILLIN
Atc Name
j 01 ca 01
Aig Number
0105872002
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
AMPICILLIN (AMPICILLIN SODIUM)
250 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
aab38f210dacb1aa
Type
Standard
Back to Health Canada Approvals